The Journal of Allergy and Clinical Immunology
Volume 121, Issue 3 , Pages 632-638.e2, March 2008

Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center

  • Colin W. Summers, MSc

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • These authors contributed equally to this work.
  • ,
  • Richard S. Pumphrey, FRCPath

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • These authors contributed equally to this work.
  • ,
  • Charlotte N. Woods, MSc

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
  • ,
  • Garry McDowell, MRCPath, PhD

      Affiliations

    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
  • ,
  • Philip W. Pemberton, MSc

      Affiliations

    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
  • ,
  • Peter D. Arkwright, FRCPCH, DPhil

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • Corresponding Author InformationReprint requests: Peter D. Arkwright, FRCPCH, DPhil, Senior Lecturer in Pediatric Immunology, University of Manchester, Department of Immunology, Manchester Royal Infirmary, Oxford Rd, Manchester, M13 9PL, United Kingdom.

Received 26 September 2007; received in revised form 4 December 2007; accepted 5 December 2007. published online 21 January 2008.

Background

Although acute allergic reactions after ingestion of peanuts and tree nuts are common, fatalities are rare. Other than patients with coexisting asthma, it is currently not possible to predict which patients are most likely to develop severe reactions.

Objective

The aim of this study was to determine which clinical and laboratory parameters best predict the likelihood of severe allergic reactions.

Methods

From 1992 to 2004, we collected detailed information on the clinical severity and allergy test results of 1094 patients with peanut and tree nut allergy attending a regional allergy center. In a subgroup of 122 patients, sera were assayed for activity of enzymes involved in the catabolism of bradykinin.

Results

Severe pharyngeal edema was 3.8 (2.1-6.9) times more common in patients with severe rhinitis and 2.6 (1.8-3.7) more common after ingestion of tree nuts compared with peanuts. Patients with serum angiotensin-converting enzyme concentrations <37.0 mmol/L had a 9.6 (1.6-57)–fold risk of severe pharyngeal edema. Life-threatening bronchospasm was most likely in patients with severe asthma (relative risk, 6.8 [4.1-11.3]) and less so in patients with milder asthma (2.7 [1.7-4.0]). Altered levels of consciousness were more likely in patients with severe eczema (3.1 [1.1-8.4]).

Conclusion

Severity of coexisting atopic diseases predicted which patients attending a tertiary referral clinic were most likely to develop life-threatening allergic reactions to peanuts and tree nuts. Patients with the lowest serum angiotensin-converting enzyme concentrations were more likely to develop life-threatening pharyngeal edema, suggesting that this complication may be partly mediated by bradykinin.

Key words: Anaphylaxis, tree nuts, peanut, atopy, asthma, ACE, aminopeptidase P, bradykinin, age

Abbreviations used: ACE, Angiotensin-converting enzyme, APP, Aminopeptidase P, SPT, Skin prick test, UK, United Kingdom

 

 Supported by the Food Standards Agency.

 Disclosure of potential conflict of interest: R. S. Pumphrey has received research support from hospital endowment funds, the Anaphylaxis Campaign, and the Food Standards Agency; was employed by the National Health Service; and has served as an expert for Her Majesty's Coroners. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)02400-1

doi:10.1016/j.jaci.2007.12.003

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 3 , Pages 632-638.e2, March 2008